Status:
COMPLETED
Haskap and Endurance Running Performance
Lead Sponsor:
Northumbria University
Collaborating Sponsors:
Mibelle Group Biochemistry
Haskapa Ltd
Conditions:
Exercise Performance
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and a...
Detailed Description
Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the interventi...
Eligibility Criteria
Inclusion
- healthy non-smoking males
- completed a 5 km run (in less than 25 minutes) within the 6 weeks prior to the study
Exclusion
- female
- allergies to fruit or dairy, currently taking any nutritional supplements (e.g. vitamins, antioxidant, herbal or sports enhancing supplements) or medication that might affect the study outcome
- history of gastrointestinal, renal or cardiovascular disease
Key Trial Info
Start Date :
April 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 8 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04837898
Start Date
April 12 2021
End Date
December 8 2021
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northumbria University
Newcastle upon Tyne, United Kingdom, NE18ST